University of Birmingham Alabama — Birmingham, Alabama

University of Birmingham Alabama is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

University of Birmingham Alabama has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC).

Sponsors: Replimune Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Birmingham Alabama?

University of Birmingham Alabama has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Birmingham Alabama conducted?

University of Birmingham Alabama has 1 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC).

Is University of Birmingham Alabama accredited by Crixeo Health?

University of Birmingham Alabama has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Birmingham Alabama?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.